The Great Healthcare Debate 7 DAYS · Free panel + drinks · 12 May · London RSVP free →
Sunday 10 May 2026

One To Watch

Avextra

A vertically-integrated medical cannabis operator focused on the development and production of regulator-approved medicines.

Company Overview

Want to Update your Company's Profile?


Latest Avextra News

Cannabis-based medicine on the rise as German firms link up
20 June 2024
More Avextra news >


Today's issue

The week in pharma: action, reaction and insight – week to May 8, 2026
Pharmaceutical
The week in pharma: action, reaction and insight – week to May 8, 2026
10 May 2026
Biotechnology
FDA expands approval of argenx’ VyvgartFDA expands approval of argenx’ Vyvgart
9 May 2026
Biotechnology
FDA nod for Partner Therapeutics’ Bizengri
9 May 2026
Pharmaceutical
Italfarmaco’s new CEO and commitment to rare disease R&D
8 May 2026
Generics
Russia experiencing sales boom of obesity drugs
8 May 2026
Pharmaceutical
EC approves new use for BMS’ Sotyktu
8 May 2026
Biotechnology
Shares dip as Gilead adjusts to acquisition costs
8 May 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze